The DOI matches its Crossref record; 113 of the 118 references it cites were found in a registry or an index.
A renaissance of neural networks in drug discovery
Abstract
INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to choose the most appropriate approach. AREAS COVERED: In this review, the authors discuss traditional and newly emerging neural network approaches to drug discovery. Their focus is on backpropagation neural networks and their variants, self-organizing maps and associated methods, and a relatively new technique, deep learning. The most important technical issues are discussed including overfitting and its prevention through regularization, ensemble and multitask modeling, model interpretation, and estimation of applicability domain. Different aspects of using neural networks in drug discovery are considered: building structure-activity models with respect to various targets; predicting drug selectivity, toxicity profiles, ADMET and physicochemical properties; characteristics of drug-delivery systems and virtual screening. EXPERT OPINION: Neural networks continue to grow in importance for drug discovery. Recent developments in deep learning suggests further improvements may be gained in the analysis of large chemical data sets. It's anticipated that neural networks will be more widely used in drug discovery in the future, and applied in non-traditional areas such as drug delivery systems, biologically compatible materials, and regenerative medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DNN methods also require substantially larger datasets to fully capitalize on their advantages76”
From QSAR without borders (2020) · cites this paper as [76]
In the citing paper
“The development of new types of DNN76 has opened up new applications, allowing simpler molecular representations, such as SMILES strings or chemical graphs to be used to generate useful toxicity (and other property) models.”
From QSAR without borders (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Gradient-based learning applied to document recognition
Lecun, Y., Bottou, L., Bengio, Y., & Haffner, P. (1998) · Proceedings of the IEEE · doi:10.1109/5.726791 · Cited by 58,805
(2014) · Cited by 33,419
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Pan, S. J., & Yang, Q. (2010) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2009.191 · Cited by 23,387
Reducing the dimensionality of data with neural networks
Hinton, G. E., & Salakhutdinov, R. R. (2006) · Science · doi:10.1126/science.1127647 · Cited by 20,928
Neural networks and physical systems with emergent collective computational abilities.
Hopfield, J. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.8.2554 · Cited by 19,270
A logical calculus of the ideas immanent in nervous activity
McCulloch, W. S., & Pitts, W. (1943) · The Bulletin of Mathematical Biophysics · doi:10.1007/bf02478259 · Cited by 18,566
Neural networks for pattern recognition
Bishop, C. (1994) · Choice Reviews Online · doi:10.5860/choice.31-5500 · Cited by 18,537
Research works printed but not linked: 9
- Baskin II, 2008, Methods Mol Biol (Clifton, NJ), 458, 137
- Burden F, 2008, Methods Mol Biol, 458, 25
- 10.1002/qsar.v28:10 · DOI
- Srivastava N, 2014, J Machine Learn Res, 15, 1929
- 10.1002/qsar.v28:6/7 · DOI
- Glorot X, 2011, Int Conf Artif Intelligence Stat, 2011, 315
- 10.1002/minf.v30.1 · DOI
- 10.1002/minf.v35.1 · DOI
- Tetko IV, 2016, Mol Inf
Cited by
Sorted by citations
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P. P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,301
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Self-citationSchneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
Rifaioğlu, A. S., Ataş, H., Martin, M. J., Çetin-Atalay, R., Atalay, V., & Doğan, T. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 549
Rodríguez-Pérez, R., & Bajorath, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01101 · Cited by 536
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2017) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 494
Machine Learning Methods in Drug Discovery
Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020) · Molecules · doi:10.3390/molecules25225277 · Cited by 460
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
Jing, Y., Bian, Y., Hu, Z., Wang, L., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0210-0 · Cited by 360
Korotcov, A. V., Tkachenko, V., Russo, D. P., & Ekins, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00578 · Cited by 367
Exposing the Limitations of Molecular Machine Learning with Activity Cliffs
van Tilborg, D., Alenicheva, A., & Grisoni, F. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01073 · Cited by 337
Chang, Y., Park, H., Yang, H., Lee, S., Lee, K.-Y., Kim, T. S., Jung, J., & Shin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27214-6 · Cited by 324
Recurrent Neural Network Model for Constructive Peptide Design
Müller, A. T., Hiss, J. A., & Schneider, G. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00414 · Cited by 270
The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery
Dzobo, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00041-4 · Cited by 300
Transformer-CNN: Swiss knife for QSAR modeling and interpretation
Karpov, P., Godin, G., & Tetko, I. V. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00423-w · Cited by 275
Self-citationEvolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery
Rodríguez-Pérez, R., & Bajorath, J. (2022) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-022-00442-9 · Cited by 305
From machine learning to deep learning: Advances in scoring functions for protein–ligand docking
Shen, C., Ding, J., Wang, Z., Cao, D., Ding, X., & Hou, T. (2019) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1429 · Cited by 255
The Next Era: Deep Learning in Pharmaceutical Research
Ekins, S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2029-7 · Cited by 249
Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment
Tracey, I., Woolf, C. J., & Andrews, N. A. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.019 · Cited by 246
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
Zhao, L., Ciallella, H. L., Aleksunes, L. M., & Zhu, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.005 · Cited by 244
Withnall, M., Lindelöf, E., Engkvist, O., & Chen, H. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-019-0407-y · Cited by 233
Natural product drug discovery in the artificial intelligence era
Saldívar‐González, F. I., Aldas-Bulos, V. D., Medina‐Franco, J. L., & Plisson, F. (2021) · Chemical Science · doi:10.1039/d1sc04471k · Cited by 235
Learning Molecular Representations for Medicinal Chemistry
Chuang, K. V., Gunsalus, L. M., & Keiser, M. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00385 · Cited by 232
Graph Convolutional Networks for Drug Response Prediction
Nguyen, T., Nguyen, G. T. T., Nguyen, T., & Le, D. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3060430 · Cited by 215
Deep Learning in Virtual Screening: Recent Applications and Developments
Kimber, T. B., Chen, Y., & Volkamer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094435 · Cited by 215
Deep learning for in vitro prediction of pharmaceutical formulations
Yang, Y., Ye, Z., Su, Y., Zhao, Q., Li, X., & Ouyang, D. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.09.010 · Cited by 199
Graph neural network approaches for drug-target interactions
Zhang, Z., Chen, L., Zhong, F., Wang, D., Jiang, J., Zhang, S., Jiang, H., Zheng, M., & Li, X. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.102327 · Cited by 190
Deep learning in pharmacogenomics: from gene regulation to patient stratification
Kalinin, A. A., Higgins, G. A., Reamaroon, N., Soroushmehr, S., Allyn-Feuer, A., Dinov, I. D., Najarian, K., & Athey, B. D. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0008 · Cited by 207
Deep learning tools for advancing drug discovery and development
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 185
Role of Artificial Intelligence and Machine Learning in Nanosafety
Winkler, D. A. (2020) · Small · doi:10.1002/smll.202001883 · Cited by 184
Self-citationDEEPred: Automated Protein Function Prediction with Multi-task Feed-forward Deep Neural Networks
Rifaioğlu, A. S., Doğan, T., Martin, M. J., Çetin-Atalay, R., & Atalay, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-43708-3 · Cited by 166
Sattarov, B., Baskin, I. I., Horvath, D., Marcou, G., Bjerrum, E. J., & Varnek, A. A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00751 · Cited by 151
Self-citationA Transformer Model for Retrosynthesis
Karpov, P., Godin, G., & Tetko, I. V. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-30493-5_78 · Cited by 150
Self-citationA Simple Representation of Three-Dimensional Molecular Structure
Axen, S. D., Huang, X., Cáceres, E. L., Gendelev, L., Roth, B. L., & Keiser, M. J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00696 · Cited by 144
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
Choudhury, C., Murugan, N. A., & Priyakumar, U. D. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.03.006 · Cited by 138
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa034 · Cited by 125
BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry
Tetko, I. V., Engkvist, O., Koch, U., Reymond, J., & Chen, H. (2016) · Molecular Informatics · doi:10.1002/minf.201600073 · Cited by 125
Self-citationWinkler, D. A., & Le, T. C. (2016) · Molecular Informatics · doi:10.1002/minf.201600118 · Cited by 123
Self-citationJain, S., Siramshetty, V. B., Alves, V. M., Muratov, E. N., Kleinstreuer, N., Tropsha, A., Nicklaus, M. C., Simeonov, A. M., & Zakharov, A. V. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01164 · Cited by 119
Lin, E., Lin, C., & Lane, H. (2020) · Molecules · doi:10.3390/molecules25143250 · Cited by 113
The Role of AI in Drug Discovery
Abbas, M. K. G., Rassam, A., Karamshahi, F., Abunora, R., & Abouseada, M. (2024) · ChemBioChem · doi:10.1002/cbic.202300816 · Cited by 119
Artificial intelligence: machine learning for chemical sciences
Karthikeyan, A., & Priyakumar, U. D. (2021) · Journal of Chemical Sciences · doi:10.1007/s12039-021-01995-2 · Cited by 113
Pham, H. H. N., Futakuchi, M., Bychkov, A., Furukawa, T., Kuroda, K., & Fukuoka, J. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.08.014 · Cited by 98
Machine learning-integrated omics for the risk and safety assessment of nanomaterials
Ahmad, F., Mahmood, A., & Muhmood, T. (2020) · Biomaterials Science · doi:10.1039/d0bm01672a · Cited by 102
Predicting oral disintegrating tablet formulations by neural network techniques
Han, R., Yang, Y., Li, X., & Ouyang, D. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.01.003 · Cited by 94
A Survey of Multi‐task Learning Methods in Chemoinformatics
Sosnin, S., Vashurina, M., Withnall, M., Karpov, P., Fedorov, M. V., & Tetko, I. V. (2018) · Molecular Informatics · doi:10.1002/minf.201800108 · Cited by 83
Self-citationPasrija, P., Jha, P. K., Upadhyaya, P., Khan, M. S., & Chopra, M. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220701091339 · Cited by 92
Vittorio, S., Lunghini, F., Morerio, P., Gadioli, D., Orlandini, S., Silva, P. J., Martinovič, J., Pedretti, A., Bonanni, D., Bue, A. D., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.024 · Cited by 88
The power of deep learning to ligand-based novel drug discovery
Baskin, I. I. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1745183 · Cited by 76
Self-citationDe Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update
Lin, E., Lin, C., & Lane, H. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01361 · Cited by 76
Benchmarking machine learning methods for modeling physical properties of ionic liquids
Baskin, I. I., Epshtein, A., & Ein‐Eli, Y. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118616 · Cited by 73
Self-citationWu, L., Huang, R., Tetko, I. V., Xia, Z., Xu, J., & Tong, W. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00373 · Cited by 73
Self-citationRecent advances in deep learning for retrosynthesis
Zhong, Z., Song, J., Feng, Z., Liu, T., Jia, L., Yao, S., Hou, T., & Song, M. (2023) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1694 · Cited by 88
Multitask Machine Learning for Classifying Highly and Weakly Potent Kinase Inhibitors
Rodríguez-Pérez, R., & Bajorath, J. (2019) · ACS Omega · doi:10.1021/acsomega.9b00298 · Cited by 65
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics
Marchetti, F., Moroni, E., Pandini, A., & Colombo, G. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00045 · Cited by 62
Machine Learning Methods in Computational Toxicology
Baskin, I. I. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7899-1_5 · Cited by 62
Self-citationGrEDeL: A Knowledge Graph Embedding Based Method for Drug Discovery From Biomedical Literatures
Sang, S., Yang, Z., Liu, X., Wang, L., Lin, H., Wang, J., & Dumontier, M. (2018) · IEEE Access · doi:10.1109/access.2018.2886311 · Cited by 61
Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T. C., Donchez, J., Tripathi, P. K., et al. (2022) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2022.100045 · Cited by 67
Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data
Irwin, B., Levell, J. R., Whitehead, T. M., Segall, M., & Conduit, G. J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00443 · Cited by 60
Lane, T. R., Foil, D. H., Minerali, E., Urbina, F., Zorn, K. M., & Ekins, S. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01013 · Cited by 60
Augmentation Is What You Need!
Tetko, I. V., Karpov, P., Bruno, E. N., Kimber, T. B., & Godin, G. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-30493-5_79 · Cited by 55
Self-citationYazar, M., & Özbek, P. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0141 · Cited by 53
Dlamini, Z., Skepu, A., Kim, N., Mkhabele, M., Khanyile, R., Molefi, T., Mbatha, S. Z., Damane, B. P., Mulaudzi, T. V., Mabongo, M., et al. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100965 · Cited by 61
Graph Transformer for Drug Response Prediction
Chu, T., Nguyen, T. T., Hải, B. D., Nguyen, Q. H., & Nguyen, T. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3206888 · Cited by 56
Success stories of AI in drug discovery - where do things stand?
Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51
Big (Bio)Chemical Data Mining Using Chemometric Methods: A Need for Chemists
Parastar, H., & Tauler, R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801134 · Cited by 51
Machine Learning in Chemoinformatics and Medicinal Chemistry
Rodríguez-Pérez, R., Miljković, F. N., & Bajorath, J. (2022) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122120-124216 · Cited by 50
Inverse‐QSPR for de novo Design: A Review
Gantzer, P., Creton, B., & Nieto‐Draghi, C. (2019) · Molecular Informatics · doi:10.1002/minf.201900087 · Cited by 51
Abekoon, T., Sajindra, H., Rathnayake, N., Ekanayake, I. U., Jayakody, A., & Rathnayake, U. (2025) · Smart Agricultural Technology · doi:10.1016/j.atech.2025.100879 · Cited by 46
Current Strategies and Applications for Precision Drug Design
Wang, C., Xu, P., Zhang, L., Huang, J. L., Zhu, K., & Luo, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00787 · Cited by 47
Toward Learned Chemical Perception of Force Field Typing Rules
Zanette, C., Bannan, C. C., Bayly, C. I., Fass, J., Gilson, M. K., Shirts, M. R., Chodera, J. D., & Mobley, D. L. (2018) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.8b00821 · Cited by 41
Tetko, I. V., Maran, U., & Tropsha, A. (2016) · Molecular Informatics · doi:10.1002/minf.201600082 · Cited by 44
Self-citationCheminformatics and artificial intelligence for accelerating agrochemical discovery
Djoumbou-Feunang, Y., Wilmot, J. T., Kinney, J., Chanda, P., Yu, P., Sader, C. A., Sharifi, M., Smith, S., Ou, J., Hu, J. K., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1292027 · Cited by 47
An overview of neural networks for drug discovery and the inputs used
Xu, Y., Yao, H., & Lin, K. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1547278 · Cited by 42
Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing
Zhao, K., & So, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_13 · Cited by 37
Deep neural network model for highly accurate prediction of BODIPYs absorption
Ksenofontov, A. A., Lukanov, M. M., Bocharov, P. S., Березин, М. Б., & Tetko, I. V. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.120577 · Cited by 39
Self-citationPuzyn, T., Jeliazkova, N., Sarimveis, H., Robinson, R. M., Lobaskin, V., Ralló, R., Richarz, A.-N., Gajewicz, A., Papadopulos, M. G., Hastings, J., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.09.037 · Cited by 41
Generative Models for Artificially‐intelligent Molecular Design
Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201880131 · Cited by 40
Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
Karger, E., & Kureljusic, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121492 · Cited by 37
ToxCast EPA in Vitro to in Vivo Challenge: Insight into the Rank-I Model
Novotarskyi, S., Abdelaziz, A., Sushko, Y., Körner, R., Vogt, J., & Tetko, I. V. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00481 · Cited by 34
Self-citationMacromolecular target prediction by self-organizing feature maps
Schneider, G., & Schneider, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1274727 · Cited by 34
Snyder, S. H., Vignaux, P. A., Ozalp, M. K., Gerlach, J., Puhl, A. C., Lane, T. R., Corbett, J., Urbina, F., & Ekins, S. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01220-4 · Cited by 34
What’s new in IBD therapy: An “omics network” approach
Fiocchi, C., & Iliopoulos, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104886 · Cited by 34
Dantas, R. F., Evangelista, T. C. S., Neves, B. J., Senger, M. R., Andrade, C. H., Ferreira, S. B., & Silva, F. P. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1654453 · Cited by 32
Rockholt, M. M., Kenefati, G., Doan, L., Chen, Z. S., & Wang, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1186418 · Cited by 39
Hoque, A., & Sunoj, R. B. (2022) · Digital Discovery · doi:10.1039/d2dd00084a · Cited by 33
Al‐Kindi, K. M., Mukherjee, K., Pandey, M. K., Arora, A., Janizadeh, S., Pham, Q. B., Anh, D. T., & Ahmadi, K. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17224-9 · Cited by 31
Machine Learning Models Identify New Inhibitors for Human OATP1B1
Lane, T. R., Urbina, F., Zhang, X., Fye, M. A., Gerlach, J., Wright, S. H., & Ekins, S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00662 · Cited by 31
Does ‘Big Data’ Exist in Medicinal Chemistry, and If So, How can It Be Harnessed?
Tetko, I. V., Engkvist, O., & Chen, H. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0163 · Cited by 27
Self-citationDeep Machine Learning for Computer-Aided Drug Design
Bajorath, J. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.829043 · Cited by 28
Prediction Accuracy of Production ADMET Models as a Function of Version: Activity Cliffs Rule
Sheridan, R. P., Culberson, J. C., Joshi, E., Tudor, M., & Karnachi, P. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00699 · Cited by 28
Baskin, I. I., & Ein‐Eli, Y. (2022) · Advanced Energy Materials · doi:10.1002/aenm.202202380 · Cited by 28
Self-citationGerdle, B. U. C., & Ghafouri, B. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1797499 · Cited by 29
Windolf, H., Erbrich, L., & Quodbach, J. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2173778 · Cited by 25
Graph Memory Networks for Molecular Activity Prediction
Pham, T., Tran, T., & Venkatesh, S. (2018) · Proceedings - International Conference on Pattern Recognition/Proceedings/International Conference on Pattern Recognition · doi:10.1109/icpr.2018.8545246 · Cited by 28
Lowdon, J. W., Ishikura, H., Kvernenes, M. K., Caldara, M., Cleij, T. J., van Grinsven, B., Eersels, K., & Diliën, H. (2021) · Computation · doi:10.3390/computation9100103 · Cited by 26
A Review of Deep Learning-Based Approaches for Detection and Diagnosis of Diverse Classes of Drugs
Kumar, A., Kumar, N., Kuriakose, J., & Kumar, Y. (2023) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-023-09936-7 · Cited by 24
Metadata
- Authors
- Baskin, I. I., Winkler, D., & Tetko, I. V.
- Affiliations
- Lomonosov Moscow State University (RU)
- Flinders University (AU)
- Helmholtz Munich (DE)
- Corresponding author
- Tetko, Igor V.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2016-07-04
- Volume
- 11
- Issue
- 8
- Pages
- 785-795
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2436108096
- Cited by
- 235
- References
- 118
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 25 · 2023: 24 · 2022: 41 · 2021: 26 · 2020: 26 · 2019: 21 · 2018: 27 · 2017: 8 · 2016: 7
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Physical Sciences › Computer Science › Artificial Intelligence › Neural Networks and Applications
- Keywords
- artificial neural networks, drug discovery, BP neural network, self-organizing maps, deep learning, overfitting, regularization, ensemble learning, model interpretability, applicability domain, structure-activity relationship, toxicity prediction, ADMET prediction, physicochemical property prediction, drug delivery systems, virtual screening
- MeSH terms
- Pharmaceutical Preparations, Humans, Models, Biological, Structure-Activity Relationship, Drug Design, Drug Delivery Systems, Neural Networks, Computer, Computer-Aided Design, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review